Microscale structural model of Alzheimer Aβ(1–40) amyloid fibril

Paparcone, Raffaella; Buehler, Markus J.
June 2009
Applied Physics Letters;6/15/2009, Vol. 94 Issue 24, p243904
Academic Journal
Amyloid fibril formation and characterization are crucial due to their association with severe degenerative disorders such as Alzheimer’s, type II diabetes, and Parkinson’s disease. Here we present an atomistic-based multiscale analysis, utilized to predict the structure of Alzheimer Aβ(1–40) fibrils. Our study provides a structural model of amyloid fibers with lengths of hundreds of nanometers at atomistic resolution. We report a systematic analysis of the energies, structural changes and H-bonding for varying fibril lengths, elucidating their size dependent properties. Our model predicts the formation of twisted amyloid microfibers with a periodicity of ≈82 nm, in close agreement with experimental results.


Related Articles

  • Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimer's Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form. Ito, Kazuhiro; Ishibashi, Ken-Ichi; Tomiyama, Takami; Umeda, Tomohiro; Yamamoto, Kei-Ichi; Kitajima, Erika; Idomoto, Toshiki; Nagatomo, Toshie; Mori, Hiroshi // Current Alzheimer Research;Apr2009, Vol. 6 Issue 2, p132 

    Oligomer Aβ is the term utilized for multimeric but non-fibrillar forms of amyloid β-protein (Aβ). The most prominent property of oligomer Aβ is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Aβ in AD brains. At present,...

  • Disruption of Calcium Homeostasis in the Pathogenesis of Alzheimer's Disease and Other Conformational Diseases. Kawahara, Masahiro // Current Alzheimer Research;Apr2004, Vol. 1 Issue 2, p87 

    Conformational changes of Alzheimer's �-amyloid protein (A�P) enhance its neurotoxicity and play important roles in the pathogenesis of Alzheimer's disease. Recent studies have suggested that a common mechanism is based on diverse �conformational diseases�. They share...

  • Acetylcholinesterase-Amyloid-�-peptide Interaction: Effect of Congo Red and the Role of the Wnt Pathway. Inestrosa, Nibaldo C.; Alvarez, Alejandra; Dinamarca, Margarita C.; P�rez-Acle, Tom�s; Colombres, Marcela // Current Alzheimer Research;Jul2005, Vol. 2 Issue 3, p301 

    The cholinergic system impairment observed in Alzheimer's disease (AD) patients leads to the cognitive, global and behavioral dysfunction commonly associated with dementia. The only treatment for AD has been the use of inhibitors of acetylcholinesterase (AChE) (E.C., which is one of the...

  • Increased A�1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity. Chafekar, Sidhartha M.; Zwart, Rob; Veerhuis, Robert; Vanderstichele, H.; Baas, Frank; Scheper, Wiep // Current Alzheimer Research;Dec2008, Vol. 5 Issue 5, p469 

    Alzheimer's disease (AD) is characterized by the aggregation and subsequent deposition of misfolded �- amyloid (A�) peptide. The unfolded protein response (UPR) is activated by misfolded protein stress in the endoplasmic reticulum (ER). In previous studies we demonstrated mild...

  • Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer's Disease. Blasko, I.; Grubeck-Loebenstein, B. // Drugs & Aging;2003, Vol. 20 Issue 2, p101 

    The dysregulation in the metabolism of β-amyloid precursor protein and consequent deposition of amyloid-β (Aβ) has been envisaged as crucial for the development of neurodegeneration in Alzheimer's disease (AD). Amyloid deposition begins 10-20 years before the appearance of clinical...

  • The Many Faces of Aβ: Structures and Activity. Walsh, Dominic M.; Hartley, Dean M.; Selkoe, Dennis J. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Dec2003, Vol. 3 Issue 4, p277 

    Although converging lines of evidence suggest a central role for amyloid ß-protein (Aß) in the etiology of Alzheimer's disease (AD), the active form(s) of Aβ that leads to altered neuronal function and death have not been definitively identified. Indeed, until recently, efforts at...

  • β-Amyloid, Neuronal Death and Alzheimer's Disease. Carter, J.; Lippa, C.F. // Current Molecular Medicine;Dec2001, Vol. 1 Issue 6, p733 

    Alzheimer's disease (AD) is a common neurodegenerative disease that affects cognitive function in the elderly. Large extracellular beta-amyloid (Aβ) plaques and tau-containing intraneuronal neurofibrillary tangles characterize AD from a histopathologic perspective. However, the severity of...

  • European scientists push spinal taps for Alzheimer diagnosis. Sinha, Gunjan // Nature Medicine;Feb2006, Vol. 12 Issue 2, p156 

    The article reports that European scientists push spinal taps for Alzheimer diagnosis to distinguish the disease from other types of dementia and to help validate therapies. The brain of an Alzheimer disease sufferer is marked by intracellular tangles composed of tau protein and abnormal...

  • Clearing the mind. Knight, Jonathan // New Scientist;07/10/99, Vol. 163 Issue 2194, p4 

    Reports on the development of a vaccine that prevented mice from getting Alzheimer's disease. Experimentation with insoluble amyloid-beta protein injections at an early age which prevented the buildup of plaques thought to trigger loss of mental faculties; Possibility that the tangles of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics